trending Market Intelligence /marketintelligence/en/news-insights/trending/bncoifdzp0q3k4paxrsphq2 content esgSubNav
In This List

Nemus Bioscience closes $1.8M private placement

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


Nemus Bioscience closes $1.8M private placement

Nemus Bioscience Inc. received about $1.8 million in the final closing of a private placement with Emerald Health Sciences Inc.

Emerald Health bought 15 million ordinary Nemus shares and warrants to buy an additional 20.4 million shares at 10 cents apiece.

On a fully converted basis, Emerald holds a majority of Nemus' outstanding share capital.

Costa Mesa, Calif.-based Nemus intends to use proceeds for working capital and to explore potential strategic opportunities.

Emerald Health and Nemus are focused on cannabinoid-based therapeutics.